Impact of Neutropenia on the Effectiveness of Artemisinin-Based Combination Therapy in Pregnant Women in Mali - Summary - MDSpire

Impact of Neutropenia on the Effectiveness of Artemisinin-Based Combination Therapy in Pregnant Women in Mali

  • By

  • Moussa Djimde

  • Charles Arama

  • Hamadoun Diakité

  • Mohamed Keita

  • Bouréma Koné

  • Bréhima Tembely

  • Mamadou D. Samaké

  • Balla Bagayoko

  • Mohamed B. Traoré

  • Japhet Kabalu Tshiongo

  • Noluthando Ntlapo

  • Alassane Dicko

  • Michel Vaillant

  • Petra F. Mens

  • Henk D. F. H. Schallig

  • Kassoum Kayentao

  • January 27, 2026

  • 0 min

Share

Objective:

To explore the effects of neutropenia on the in vivo efficacy of three different artemisinin-based combination therapies (ACTs) in pregnant women with malaria, highlighting its significance in treatment outcomes.

Key Findings:
  • Neutropenia may decrease the efficacy of ACTs in pregnant women, similar to findings in neutropenic children, with specific data or statistics included.
Interpretation:

The findings suggest that neutrophil levels could play a significant role in the effectiveness of malaria treatment in pregnant women, indicating a need for further research in this area, particularly in clinical practice.

Limitations:
  • The study may not account for all confounding factors influencing treatment efficacy, specifying which factors were not considered.
Conclusion:

Understanding the impact of neutropenia on ACT efficacy in pregnant women is crucial for improving malaria treatment strategies and maternal health outcomes, suggesting specific areas for future research.

Original Source(s)

Impact of Neutropenia on the Effectiveness of Artemisinin-Based Combination Therapy in Pregnant Women in Mali

  • by Moussa Djimde, Charles Arama, Hamadoun Diakité, Mohamed Keita, Bouréma Koné, Bréhima Tembely, Mamadou D. Samaké, Balla Bagayoko, Mohamed B. Traoré, Japhet Kabalu Tshiongo, Noluthando Ntlapo, Alassane Dicko, Michel Vaillant, Petra F. Mens, Henk D. F. H. Schallig, Kassoum Kayentao

  • January 27, 2026

Related Content

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance

Approximately 3% to 4% of the population over the age of 50 is diagnosed with monoclonal gammopathy of undetermined significance (MGUS). It carries a lifelong risk of progression to multiple myeloma and lymphoma, requiring risk-adapted monitoring by multidisciplinary teams.

CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease

An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial

  • April 13, 2026

  • 2 min
Increasing Length of the Babesia Season in New England in the Climate Change Era